Day CA - Search Results

1

Uptake of direct acting antiviral therapies for the treatment of hepatitis C virus among people who inject drugs in a universal health-care system.

Butler K, Larney S, Day CA, Burns L. Butler K, et al. Among authors: day ca. Drug Alcohol Rev. 2019 Mar;38(3):264-269. doi: 10.1111/dar.12883. Epub 2018 Dec 12. Drug Alcohol Rev. 2019. PMID: 30548702

2

Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia.

Topp L, Day C, Degenhardt L. Topp L, et al. Drug Alcohol Depend. 2003 Jun 5;70(3):275-86. doi: 10.1016/s0376-8716(03)00013-9. Drug Alcohol Depend. 2003. PMID: 12757965

3

Hepatitis C-related discrimination among heroin users in Sydney: drug user or hepatitis C discrimination?

Day C, Ross J, Dolan K. Day C, et al. Drug Alcohol Rev. 2003 Sep;22(3):317-21. doi: 10.1080/0959523031000154463. Drug Alcohol Rev. 2003. PMID: 15385226

4

Age differentials in the impacts of reduced heroin: effects of a "heroin shortage" in NSW, Australia.

Degenhardt L, Day C, Conroy E, Gilmour S, Hall W. Degenhardt L, et al. Drug Alcohol Depend. 2005 Sep 1;79(3):397-404. doi: 10.1016/j.drugalcdep.2005.03.028. Drug Alcohol Depend. 2005. PMID: 15927418

5

The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence.

Degenhardt L, Conroy E, Day C, Gilmour S, Hall W. Degenhardt L, et al. Drug Alcohol Depend. 2005 Aug 1;79(2):129-35. doi: 10.1016/j.drugalcdep.2005.01.018. Epub 2005 Mar 2. Drug Alcohol Depend. 2005. PMID: 16002022

6

Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.

White B, Day C, Degenhardt L, Kinner S, Fry C, Bruno R, Johnston J. White B, et al. Drug Alcohol Depend. 2006 Jul 27;83(3):210-7. doi: 10.1016/j.drugalcdep.2005.11.014. Epub 2005 Dec 15. Drug Alcohol Depend. 2006. PMID: 16343810

7

Correlates of hepatitis C testing among heroin injectors in Sydney.

Day C, Dolan K. Day C, et al. Health Promot J Austr. 2006 Apr;17(1):70-2. doi: 10.1071/he06070. Health Promot J Austr. 2006. PMID: 16619940

8

Changes in the initiation of heroin use after a reduction in heroin supply.

Day C, Degenhardt L, Hall W. Day C, et al. Drug Alcohol Rev. 2006 Jul;25(4):307-13. doi: 10.1080/09595230600741040. Drug Alcohol Rev. 2006. PMID: 16854655

9

Blood-borne virus prevalence and risk among steroid injectors: results from the Australian Needle and Syringe Program Survey.

Day CA, Topp L, Iversen J, Maher L; Collaboration of Australian NSPs. Day CA, et al. Drug Alcohol Rev. 2008 Sep;27(5):559-61. doi: 10.1080/09595230801956132. Drug Alcohol Rev. 2008. PMID: 18608447 No abstract available.

10

Injecting drug users' understanding of hepatitis C.

O'Brien S, Day C, Black E, Dolan K. O'Brien S, et al. Addict Behav. 2008 Dec;33(12):1602-5. doi: 10.1016/j.addbeh.2008.07.005. Epub 2008 Jul 22. Addict Behav. 2008. PMID: 18762384

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters